Daily News

E&C Dems Praise 340B Providers, GOP Worried By Lack Of Program Data

October 11, 2017
House Energy & Commerce Democrats on Wednesday (Oct. 11) touted 340B providers and the programs run off of savings received through that drug discount program, but committee Chair Greg Walden (R-OR) said he was worried about the lack of transparency and dearth of data on how the providers use the program. Republicans at the Energy & Commerce oversight subcommittee hearing said that lawmakers on both sides of the aisle support the 340B program, but Rep. Buddy Carter (R-GA) said Congress...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.